CPHA Canvax

On January 12, 2024, the Public Health Agency of Canada (PHAC) released the National Advisory Committee on Immunization's (NACI) Guidance on an additional dose of COVID-19 vaccines in the spring of 2024 for individuals at high risk of severe illness due to COVID-19. This guidance is based on current evidence and NACI expert opinion.


Rating See Comments Ratings


Program Planning and Delivery,Clinics,Vaccine Preventable Diseases,COVID-19,Vaccine Safety and Development,Sub Topics: Vaccine Safety and Development,Vaccine Effectiveness and Efficacy Program Planning and Delivery
Vaccine Preventable Diseases
Vaccine Safety and Development
Sub Topics: Vaccine Safety and Development
Vaccine Effectiveness and Efficacy


Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.